Avexxin's Series A Round

Avexxin raised a round of funding on January 09, 2012.

Avexxin focuses on the development of small molecule therapeutics for patients suffering from chronic inflammatory conditions. Avexxin's advanced understanding of the biology of the inflammatory proce…

Articles about Avexxin's Series A Round: